Theranostics in Nuclear Medicine
Corresponding author: [email protected]
Abstract
Theranostics is the use of one molecular target for both diagnosis and therapy: a radiopharmaceutical carrying an imaging radionuclide first shows where the target is expressed, and a closely matched radiopharmaceutical carrying a therapeutic radionuclide then delivers a cytotoxic radiation dose to the same sites. The working motto of the discipline, “see what you treat, treat what you see”, states the logic in six words: the image is no longer only a description of disease but the selection test for treatment and, afterwards, the record of where the radiation went. This chapter traces the historical development from radioiodine to radioligand therapy, the theranostic pair concept, the construct of a theranostic radiopharmaceutical, the radiation physics of therapeutic emissions, the radionuclides used, clinical applications, patient selection, protocol and administration, dosimetry principles, and the role of the radiographer and nuclear medicine technologist.
Author Affiliations
- 1 Scholar, Saraswati College of Pharmacy, SGC Group, Gharuan 140413, Mohali, Punjab, India.